CDER Guidance Agenda 2004: Pregnancy, Pediatric Studies Are Priorities

FDA is planning several new guidances to refine recommendations for drug studies in children and pregnant women during 2004, the Center for Drug Evaluation & Research's guidance agenda for the coming year indicates